Literature DB >> 14693796

Intravitreal triamcinolone acetonide for ischaemic macular oedema caused by branch retinal vein occlusion.

S D M Chen, J Lochhead, C K Patel, P Frith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14693796      PMCID： PMC1771941          DOI： 10.1136/bjo.88.1.154

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  10 in total

1.  Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion.

Authors:  Paul B Greenberg; Adam Martidis; Adam H Rogers; Jay S Duker; Elias Reichel
Journal:  Br J Ophthalmol       Date:  2002-02       Impact factor: 4.638

2.  Intraocular pressure after intravitreal injection of triamcinolone acetonide.

Authors:  J B Jonas; I Kreissig; R Degenring
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

3.  Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis.

Authors:  S Young; G Larkin; M Branley; S Lightman
Journal:  Clin Exp Ophthalmol       Date:  2001-02       Impact factor: 4.207

4.  Intravitreal triamcinolone for refractory diabetic macular edema.

Authors:  Adam Martidis; Jay S Duker; Paul B Greenberg; Adam H Rogers; Carmen A Puliafito; Elias Reichel; Caroline Baumal
Journal:  Ophthalmology       Date:  2002-05       Impact factor: 12.079

5.  Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1 (ICAM-1) expression of the ECV304 cell line: implications for macular degeneration.

Authors:  P L Penfold; L Wen; M C Madigan; M C Gillies; N J King; J M Provis
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

6.  Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group.

Authors: 
Journal:  Am J Ophthalmol       Date:  1984-09-15       Impact factor: 5.258

7.  Retinal branch vein occlusion: a study of argon laser photocoagulation in the treatment of macular oedema.

Authors:  J S Shilling; C A Jones
Journal:  Br J Ophthalmol       Date:  1984-03       Impact factor: 4.638

8.  Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema.

Authors:  Mandi D Conway; Christina Canakis; Charalampos Livir-Rallatos; Gholam A Peyman
Journal:  J Cataract Refract Surg       Date:  2003-01       Impact factor: 3.351

9.  Ischemic macular edema. Recognition and favorable natural history in branch vein occlusion.

Authors:  D Finkelstein
Journal:  Arch Ophthalmol       Date:  1992-10

10.  Prognostic factors for retinal vein occlusion: prospective study of 175 cases.

Authors:  A Glacet-Bernard; G Coscas; A Chabanel; A Zourdani; F Lelong; M M Samama
Journal:  Ophthalmology       Date:  1996-04       Impact factor: 12.079
  10 in total
  14 in total

Review 1.  The management of retinal vein occlusion: is interventional ophthalmology the way forward?

Authors:  H Shahid; P Hossain; W M Amoaku
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

2.  Intravitreous bevacizumab in the treatment of macular edema from branch retinal vein occlusion and hemisphere retinal vein occlusion (an AOS thesis).

Authors:  Gary Edd Fish
Journal:  Trans Am Ophthalmol Soc       Date:  2008

3.  Combined intravitreal triamcinolone injection and laser photocoagulation in eyes with persistent macular edema after branch retinal vein occlusion.

Authors:  Juliane Riese; Vlassis Loukopoulos; Cornelia Meier; Melanie Timmermann; Heinrich Gerding
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-08-16       Impact factor: 3.117

4.  Intraocular pressure elevation following triamcinolone acetonide administration as related to administration routes.

Authors:  Yoshio Hirano; Takeshi Ito; Miho Nozaki; Tsutomu Yasukawa; Eiji Sakurai; Munenori Yoshida; Yuichiro Ogura
Journal:  Jpn J Ophthalmol       Date:  2009-10-22       Impact factor: 2.447

5.  Long-term efficacy and duration of action of dexamethasone implant, in vitrectomised and non-vitrectomised eyes with persistent diabetic macular oedema.

Authors:  George G Bastakis; Dimitris Dimopoulos; Anastasios Stavrakakis; George Pappas
Journal:  Eye (Lond)       Date:  2018-10-09       Impact factor: 3.775

6.  Hypothalamic-pituitary-adrenal axis function following intravitreal triamcinolone acetonide injection.

Authors:  Maoz D Amiran; Sonia N Yeung; Yaron Lang; Gil Sartani; Avraham Ishay; Rafael Luboshitzky
Journal:  Int Ophthalmol       Date:  2012-11-07       Impact factor: 2.031

7.  Retinal sensitivity improvement after intravitreal triamcinolone acetonide injection for macular edema secondary to branch retinal vein occlusion.

Authors:  Fevzi Senturk; Hakan Ozdemir; Murat Karacorlu; Serra Arf Karacorlu; Omer Uysal
Journal:  Indian J Ophthalmol       Date:  2013 Jan-Feb       Impact factor: 1.848

8.  Relationship between grades of macular perfusion and foveal thickness in branch retinal vein occlusion.

Authors:  Susumu Sakimoto; Motohiro Kamei; Mihoko Suzuki; Shinsaku Yano; Nagakazu Matsumura; Hirokazu Sakaguchi; Fumi Gomi; Kohji Nishida
Journal:  Clin Ophthalmol       Date:  2012-12-31

9.  Early versus late intravitreal triamcinolone acetonide for macular edema associated with branch retinal vein occlusion.

Authors:  Joo Youn Oh; Je Hyun Seo; Jae Kyoun Ahn; Jang Won Heo; Hum Chung
Journal:  Korean J Ophthalmol       Date:  2007-03

10.  Use of intravitreal triamcinolone in the treatment of macular edema related to retinal vein occlusion.

Authors:  Ashish Sharma; Baruch D Kuppermann; M Cristina Kenney
Journal:  Open Ophthalmol J       Date:  2008-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.